Top Medical News

New Anti-Tuberculosis Regimen Cures 2 Months Earlier

May 9th 2021

Rifapentine-moxifloxacin based anti-tuberculosis regimen shortened the conventional six-month course of treatment to four.

Public Health Watch: Military Study Suggests SARS-CoV-2 Immunity May Last Up to 1 Year in Some

May 9th 2021

Protection from “natural infection” may last longer in older adults, authors say.

Exercise May Aid in Recovery of Long Lasting COVID-19 Symptoms

May 8th 2021

Patients who completed a 6 week rehabilitation program showed statistically significant improvement in exercise capacity, overall wellbeing and cognition.

Novavax and Gavi Announce Purchase Agreement for COVAX Facility

May 7th 2021

Novavax plans to deliver approximately 350 million doses to COVAX during the third quarter of 2021.

China’s Sinopharm COVID-19 Vaccine Approved by WHO

May 7th 2021

The vaccine will now be included in WHO’s COVAX initiative, which is providing greater and more equitable access to vaccines around the world.

Most Recent